The Global olanzapine market is experiencing steady yet resilient growth, projected to expand from USD 2.3 billion in 2023 to USD 3.1 billion by 2032-a compound annual growth rate (CAGR) of 4.9%-as mental health disorders surge worldwide and treatment paradigms evolve toward early intervention, long-term stabilization, and patient-centric delivery. Olanzapine,...